<DOC>
	<DOCNO>NCT02740114</DOCNO>
	<brief_summary>Bupivacaine drug traditionally give injection numb surgical site . Liposomes molecules similar fat . Sometimes drug combine liposome make able stay body long period time . This do bupivacaine create liposomal bupivacaine . The goal clinical research study compare effect bupivacaine liposomal bupivacaine give patient gynecologic surgery . Researchers want compare long drug work numb wound long patient take recover surgery .</brief_summary>
	<brief_title>Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine Patient 's Undergoing Open Gynecologic Surgery Enhanced Recovery Pathway</brief_title>
	<detailed_description>Study Arms Drug Administration : If find eligible take part study , randomly assign ( flip coin ) 1 2 study arm : - If Arm 1 , receive bupivacaine . - If Arm 2 , receive combination liposomal bupivacaine bupivacaine . You equal ( 50/50 ) chance assign either group . You know receive . However , study staff know receive . In case , drug ( ) inject skin tissue end surgery , right wound close . Study Data Collection : Every day hospital recover surgery , ask question pain , side effect may , symptom , opioid use . Within 30 day leave hospital , may also call ask side effect may . If call , call last 10-15 minute . This information may also collect routinely schedule clinic visit medical record . Three ( 3 ) 7 day leave hospital , 1 time every week total 8 week , call email ask question symptom may . If call , call last 10-15 minute . If also enrol study BS99-094 `` Measuring Symptom Distress Cancer Patients : Development New Assessment System , '' information participation study may also collect use study . Length Study : Your participation study 8 week leave hospital . This investigational study . Both bupivacaine liposomal bupivacaine FDA approve commercially available . It investigational compare 2 drug . Up 200 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Genital Neoplasms , Female</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>1 . Undergoing exploratory laparotomy suspect gynecologic cancer , include metastatic disease neoplasia originate organ 2 . Planned participation Gynecologic Enhanced Recovery Pathway 3 . Female 18 year age old 4 . Patient must able read speak English 5 . Consents part randomize , singleblinded study 6 . Patient physical mental capability take part study 7 . Bilirubin le equal 1.5 x upper limit normal range ( ULN ) ; Serum Glutamic Oxaloacetic Transaminase ( SGOT ) Serum GlutamicPyruvic Transaminase ( SGPT ) &lt; /=2.5 x ULN 8 . If patient childbearing potential , patient must negative blood urine pregnancy test within 14 day surgical treatment study 1 . Sensitivity amidetype local anesthetic 2 . Patients longacting opioid medication , schedule ( four time day seven day ) shortacting opioid medication within last 30 day 3 . Emergency surgery type allow proper time protocol review patient 4 . Surgery involve known/anticipated resection anterior abdominal wall plastic surgery reconstruction 5 . Patients undergo pelvic exenteration 6 . Patients undergo known/anticipated anterior abdominal wall hernia repair 7 . Patients weigh &lt; 50 kg</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Malignant neoplasm female genital organ</keyword>
	<keyword>Open gynecologic surgery</keyword>
	<keyword>Local wound infiltration</keyword>
	<keyword>Gynecologic cancer</keyword>
	<keyword>Bupivacaine</keyword>
	<keyword>Liposomal Bupivacaine</keyword>
	<keyword>Oxycodone</keyword>
	<keyword>ETH-Oxydose [ DSC ]</keyword>
	<keyword>OxyContin</keyword>
	<keyword>OxyIR</keyword>
	<keyword>Roxicodone</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
	<keyword>MD Anderson Symptom Inventory</keyword>
	<keyword>MDASI</keyword>
	<keyword>Pill diary</keyword>
	<keyword>Medication log</keyword>
</DOC>